SITEMAP
- Events
- Legal Notice
- Cookie Policy
- Privacy Policy
- Login
- Register
- Patient Support
- Search
- Activate your Sanofi Account
-
Science
- Acquired Thrombotic Thrombocytopenic Purpura (ATTP)
-
Anti-Infectives
-
Asthma
-
Atopic Dermatitis
-
Cardiovascular
-
Atherothrombosis
-
Cutting Edge Science
- Innovation
-
2022
- In hospital outcomes in young patients with AMI: Results from Gulf Coast
- Adherence and persistence analysis in patients treated with DAPT
- Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)
- Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice
- Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?
- 2023
-
Cutting Edge Science
-
Dyslipidemia
-
Hypertension
-
Thrombosis
-
Atherothrombosis
-
Chronic Obstructive Pulmonary Disease
- Diabetes
-
Eosinophilic Esophagitis
-
Multiple Myeloma
-
Multiple Sclerosis
-
Nasal Polyps
- Neurological Disorders
- Multiple Myeloma
- Prurigo Nodularis
- Rare Diseases
- Vaccines
- Error 404
- Products
- Oman Contact Details
-
Events Calendar